SCMP -Sucampo Pharma files patent infringement lawsuit against Anchen Pharmaceuticals and Par Pharmaceuticals (SCMP) 5.22 : Co announced that it, its affiliate Sucampo AG, R-Tech Ueno, Takeda Pharmaceutical (TKPYY) and certain affiliates of Takeda have filed a patent infringement lawsuit in the United States District Court for the District of Delaware against Anchen Pharmaceuticals, Par Pharmaceuticals, and Par Pharmaceutical related to an Abbreviated New Drug Application (ANDA) that Anchen filed with the FDA to market a generic version of AMITIZA (lubiprostone) oral capsules, 8 mcg and 24 mcg. The lawsuit claims infringement of six patents that are listed in the FDA's Orange Book and that are scheduled to expire between 2020 and 2027.
